Dr. Emmett T. Cunningham Jr., MD, MPH, PhD

Dr. Cunningham practices at West Coast Retina in San Francisco, California.

Dr. Cunningham's NPI, 1083706261, was assigned on September 28, 2006. Dr. Cunningham graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Cunningham's California license number on file is A051186.

Dr. Cunningham's primary practice is West Coast Retina, at 1445 Bush St, San Francisco, CA 94109-5520. The practice phone is (415) 972-4600.

Dr. Cunningham's primary practice is West Coast Retina in San Francisco, California. Dmand AI also links Dr. Cunningham to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cunningham practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Cunningham's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Cunningham is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Cunningham's licenses on file in 2 states: California and New York.

Dmand AI lists inflammation of iris, retinal occlusion and scleritis among the conditions Dr. Cunningham treats.

CMS data shows 78 Medicare services from Dr. Cunningham across 3 procedure codes in 2024, for 18 Medicare patients. Medicare paid $5,646 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Cunningham in 2024. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cunningham's median patient age at 55, with 50% women.

In 2024, Dr. Cunningham wrote 13 Medicare Part D claims. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $6,474 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cunningham for performance year 2024, reported as part of a group. Dr. Cunningham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 220 papers to Dr. Cunningham, published from 2005 to 2024. 2021 was the busiest year, with 10. The most frequent topics are Fluorescein Angiography, Uveitis and Visual Acuity. Dr. Cunningham has published most often in Ocul Immunol Inflamm. Dr. Cunningham's most frequent co-authors are Robert N. Johnson, MD, J Michael Jumper, MD and Brandon Lujan, MD.

CMS Open Payments shows 36 general payments to Dr. Cunningham from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Turing Pharmaceuticals paid the most, $13,600.

Dmand AI lists 1 award for Dr. Cunningham.

Dr. Cunningham graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Cunningham is a member of AAO.

Dr. Cunningham is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.